How to predict response to anti-tumour necrosis factor agents in inflammatory bowel disease (vol 12, pg 1, 2018)

被引：0
|
作者：
Naviglio, S.
Giuffrida, P.
Stocco, G.
机构：
来源：
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY | 2018年 / 12卷 / 08期
关键词：
D O I：
10.1080/17474124.2018.1500981
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：I / I
页数：1
相关论文
共 50 条
  • [31] Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease
    Shale, M. J.
    Seow, C. H.
    Coffin, C. S.
    Kaplan, G. G.
    Panaccione, R.
    Ghosh, S.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 31 (01) : 20 - 34
  • [32] Systematic review with meta-analysis: comparative risk of lymphoma with anti-tumour necrosis factor agents and/or thiopurines in patients with inflammatory bowel disease
    Chupin, Antoine
    Perduca, Vittorio
    Meyer, Antoine
    Bellanger, Christophe
    Carbonnel, Franck
    Dong, Catherine
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (08) : 1289 - 1297
  • [33] Predictors of drug survival: A cohort study comparing anti-tumour necrosis factor agents using the Swedish inflammatory bowel disease quality register
    Visuri, Isabella
    Eriksson, Carl
    Olen, Ola
    Cao, Yang
    Mardberg, Emelie
    Grip, Olof
    Gustavsson, Anders
    Hjortswang, Henrik
    Karling, Pontus
    Montgomery, Scott
    Myrelid, Par
    Ludvigsson, Jonas F.
    Halfvarson, Jonas
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (07) : 931 - 943
  • [34] Reporting the response to anti-tumour necrosis factor treatment
    Volc, S.
    Ghoreschi, K.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (05) : 867 - 868
  • [35] Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Anti-tumour Necrosis Factor Alpha Agents: A Systematic Review and Meta-analysis
    Yang, Chen
    Huang, Junlin
    Huang, Xiaowen
    Huang, Shaozhuo
    Cheng, Jiaxin
    Liao, Weixin
    Chen, Xuewen
    Wang, Xueyi
    Dai, Shixue
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 (09): : 1042 - 1052
  • [36] Tumour necrosis factor and inflammatory bowel disease
    Densem, CG
    [J]. BRITISH JOURNAL OF SURGERY, 1998, 85 (01) : 138 - 138
  • [37] Tumour necrosis factor and inflammatory bowel disease
    Armstrong, AM
    Gardiner, KR
    Kirk, SJ
    Halliday, MI
    Rowlands, BJ
    [J]. BRITISH JOURNAL OF SURGERY, 1997, 84 (08) : 1051 - 1058
  • [38] Asthenoazoospermia in patients receiving anti-tumour necrosis factor α agents
    La Montagna, G
    Malesci, D
    Buono, R
    Valentini, G
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (11) : 1667 - 1667
  • [39] Effectiveness of anti-tumour necrosis factor-α therapy in Danish patients with inflammatory bowel diseases
    Bank, Steffen
    Andersen, Paal Skytt
    Burisch, Johan
    Pedersen, Natalia
    Roug, Stine
    Galsgaard, Julie
    Turino, Stine Ydegaard
    Brodersen, Jacob Broder
    Rashid, Shaista
    Avlund, Sara
    Olesen, Thomas Bastholm
    Green, Anders
    Hoffmann, Hans Jurgen
    Thomsen, Marianne Kragh
    Thomsen, Vibeke Ostergaard
    Nexo, Bjorn Andersen
    Vogel, Ulla
    Andersen, Vibeke
    [J]. DANISH MEDICAL JOURNAL, 2015, 62 (03):
  • [40] What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails?
    Lawrance, Ian C.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (05) : 1248 - 1258
12345